Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib—A Real-Life Longitudinal Study

SIMPLE SUMMARY: Myelofibrosis is a rare blood cancer, the onset of which usually occurs at an advanced age. Real-life studies on the influence of ruxolitinib on therapeutic results and patient survival are scarce for the disease both worldwide and in Bulgaria, provoking our interest towards this top...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoeva, Vera, Mihaylov, Georgi, Mitov, Konstantin, Petrova, Guenka, Tachkov, Konstantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605047/
https://www.ncbi.nlm.nih.gov/pubmed/37894452
http://dx.doi.org/10.3390/cancers15205085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605047/
https://www.ncbi.nlm.nih.gov/pubmed/37894452
http://dx.doi.org/10.3390/cancers15205085

Ejemplares similares